HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines

HIV 疫苗设计和开发团队，A 部分 - 预防疫苗

• 批准号: 8751629
• 金额: $ 218.68万
• 依托单位: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-27 至 2015-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8751629
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Contracts; Development; Epidemic; Evaluation; Goals; HIV vaccine; Human; Staging; Vaccine Design; Vaccines; Work; immunogenic; stem; therapeutic vaccine; vaccine candidate; vaccine development

The contract is for the development of efficacious preventative and therapeutic vaccines against HIV/AIDS for worldwide use in stemming the AIDS epidemic. Work to advance vaccine concepts toward the product stage, with the long-range goal of the development of new safe and immunogenic vaccine candidates that merit further evaluation in larger human trials will be supported.

该合同旨在开发有效的艾滋病毒/艾滋病预防和治疗疫苗，供全球使用以遏制艾滋病流行。将支持将疫苗概念推进产品阶段的工作，其长期目标是开发新的安全且具有免疫原性的候选疫苗，这些候选疫苗值得在更大规模的人体试验中进行进一步评估。